Abstract
Acute rhabdomyolysis has rarely been reported after cytotoxic chemotherapy, including cytarabine and 5-azacytidine. We observed a case of acute rhabdomyolysis and renal failure after treatment with mitoxantrone and cyclophosphamide. No other cause of muscle injury could be identified, although biochemical analysis of a muscle biopsy specimen revealed a deficiency of muscle phosphorylase activity. Retreatment with doxorubicin and paclitaxel was not associated with recurrent rhabdomyolysis.
Similar content being viewed by others
References
Gabow, P.A., Kaehny, W.A. and Kelleher, S.P. (1982) The spectrum of rhabdomyolysis.Medicine 61, 141–8.
Chichmanina, R.M., Mignot, G. and Spreux, A. (1991) Drug-induced rhabdomyolysis.Ann. Med. Intern. 142, 591–7.
Papakonstantinou, C., Papanastaiou, K., Kotsopopoulou, M.et al. (1991) Chemotherapy related acute rhabdomyolysis.J. Natl. Cancer Inst. 84, 536–7.
Margolis, D., Ross, E. and Miller, K.B. (1987) Rhabdomyolysis associated with high dose cytarabine.Cancer Treat. Rep. 71, 1325–6.
Koeffler, H.P. and Haskell, C.M. (1978) Rhabdomyolysis as a complication of 5-azacytadine.Cancer Treat. Rep. 62, 573–4.
Speyer, J.L., Green, M.D., Zeleniuch-Jacquotte, A.et al. (1992) ICRF-187 permits longer treatment with doxorubicin in women with breast cancer.J. Clin. Oncol. 10, 117–27.
Estorch, M., Carrio, I., Martinez-Duncker, D., Berna, L., Torres, G., Alonso, C. and Ojeda, B. (1993) Myocyte cell damage after administration of doxorubicin or mitoxan-trone in breast cancer patients assessed by Indium 111 antimyosin monoclonal antibody studies.J. Clin. Oncol. 11, 1264–8.
Ayash, L.J., Wright, J.E., Tretyakov, O.et al. (1992) Cyclophosphamide pharmacokinetics: correlation with cardiac toxicity and tumor response.J. Clin. Oncol. 10, 995–1000.
Lewkow, L.M., Hooker, J.L. and Movahed, A. (1992) Cardiac complications of intensive dose mitoxantrone and cyclophosphamide with autologous bone marrow transplantation in metastatic breast cancer.Int. J. Cardiol. 34, 273–6.
Rago, R.P., Miles, J.M., Sufit, R.L. and Spriggs, W.G. (1994) Suramin induced weakness from hypophosphatemia and mitochondrial myopathy.Cancer 73, 1954–8.
Dalakas, M.C., Illa, I., Pezeshkpour, G.H., Laukaitis, J.P., Cohn, B. and Griffen, J.L. (1990) Mitochondrial myopathy caused by long term zidovudine therapy.N. Engl. J. Med. 322, 1098–105.
Tonin, P., Lewis, P., Servidel, S. and DiMauro, S. (1990) Metabolic causes of myoglobinuria.Ann. Neurol. 27, 181–5.
DiMauro, S. and Bresolin, N. (1986) Phosphorylase Deficiency. In A.G. Engel and B.Q. Banker (eds)Myology, pp. 1585–601. New York: McGraw-Hill.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Levy, R.J., Sparano, J.A. & Khan, G. Rhabdomyolysis: An unusual complication of cytotoxic chemotherapy. Med Oncol 12, 219–222 (1995). https://doi.org/10.1007/BF02990567
Issue Date:
DOI: https://doi.org/10.1007/BF02990567